A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Clinical trial NCT01434186 · COMPLETED
Trial details
- NCT number
- NCT01434186
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.